Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03626363 · ClinicalTrials.gov registry record · NA
Mindfulness and Neural Cardiovascular Control in Humans
A NA study, sponsored by Michigan Technological University.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT03626363 is a NA study that has completed, run by Michigan Technological University. The registered enrollment target is 52 participants.
The verdict
NCT03626363, a NA study, has completed, sponsored by Michigan Technological University.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study evaluates the impact of mindfulness-based stress reduction (MBSR) on sympathetic nerve activity and arterial stiffness. The investigator's central hypothesis is that MBSR will reduce sympathetic activity and arterial stiffness.
Interventions
- BEHAVIORAL Stress Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03626363
The ClinicalTrials.gov registry entry for NCT03626363 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan Technological University, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stress Management is the first listed.
NCT03626363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03626363 about?
NCT03626363 is a clinical study titled "Mindfulness and Neural Cardiovascular Control in Humans". This study evaluates the impact of mindfulness-based stress reduction (MBSR) on sympathetic nerve activity and arterial stiffness. The investigator's central hypothesis is that MBSR will reduce sympathetic activity and arterial stiffness.
What is the current status of trial NCT03626363?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2018-09-04. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03626363?
The interventions under investigation include: Stress Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03626363?
This trial is sponsored by Michigan Technological University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.